A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Name: A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Published: 2023
License: Public Domain

Q32 Bio Inc. · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

dermatitis

alopecia areata, areata, alopecia, alopecia, dermatitis, hair loss, trichoscopy, atopic, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Related documents